Image from Google Jackets

Palliative Care Formulary 6

By: Contributor(s): Publication details: London : Pharmaceutical Press, 2017Edition: 6thISBN:
  • 0857113488
  • 9780857113481
Subject(s):
Contents:
Part I - Drug Monographs; Part 2 - Prescribing in palliative care; Part 3 - Routes of administration; Appendices
Summary: The sixth edition of Palliative Care Formulary is an essential resource for clinicians who prescribe for patients with progressive end-stage disease. Although written primarily with cancer patients in mind, PCF6 contains specific material relating to several other life-limiting diseases e.g. COPD, congestive heart failure, renal failure, and Parkinson's disease. PCF also includes a number of Quick Clinical Guides. This comprehensive title includes independent information about drugs used in palliative care, highlighting off-label indications or routes, and dealing with the administration of multiple drugs by continuous subcutaneous infusion.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number Status Date due Barcode
Book David Adams Library (Royal Marsden) Shelves QV4 TWY (Browse shelf(Opens below)) Available 0000007329

Part I - Drug Monographs; Part 2 - Prescribing in palliative care; Part 3 - Routes of administration; Appendices

The sixth edition of Palliative Care Formulary is an essential resource for clinicians who prescribe for patients with progressive end-stage disease. Although written primarily with cancer patients in mind, PCF6 contains specific material relating to several other life-limiting diseases e.g. COPD, congestive heart failure, renal failure, and Parkinson's disease. PCF also includes a number of Quick Clinical Guides. This comprehensive title includes independent information about drugs used in palliative care, highlighting off-label indications or routes, and dealing with the administration of multiple drugs by continuous subcutaneous infusion.

There are no comments on this title.

to post a comment.
London Health Libraries Koha Consortium privacy notice